{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"19.75","upperLimit":"28","value":"23"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Time (in days) to ANC of \\> 1,000/uL, counted as the first of three consecutive days post-transplant","dispersionType":"Inter-Quartile Range","groups":[{"description":"All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis","id":"OG000","title":"Overall Study Participants"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Time to ANC of > 1,000/uL","type":"SECONDARY","unitOfMeasure":"Days"}